Cover Image
Market Research Report

Europe Proteomics Market Forecast 2019-2027

Published by Inkwood Research Product code 823177
Published Content info 112 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Proteomics Market Forecast 2019-2027
Published: April 15, 2019 Content info: 112 Pages
Description

KEY FINDINGS

The advancement in proteomic technologies, increase in R&D expenditure, technological advancements and the increasing use of proteomics information are essentially driving the market in the Europe regional market for proteomics. The Europe proteomics market is anticipated to generate revenue of $XX billion by 2027 and to grow at a CAGR of 14.49% between 2019 and 2027.

MARKET INSIGHTS

The European proteomics market includes Germany, France, the UK, Italy, Spain and Rest of Europe. Europe has emerged as the second largest potential market for proteomics. As proteomic technologies are applicable in a wide range of clinical studies, the European Commission co-funded a project on proteomics by investing $XX million in 2015 for four years under the Horizon 2020 Program.

Proteomics research requires huge capital investment, which is supported by public funding institutions but results in a low outcome. The proteomics market is expected to witness significant growth. Therefore, the government and federal ministries across several countries in the region have invested in the industry to drive the market growth.

COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc., Bruker Corporation, Danaher Corporation, Merck & Company Inc., GlaxoSmithKline, Agilent Technologies, Inc., LI-COR Inc., General Electric Company, Luminex Corp., PerkinElmer, Inc., Horiba, Ltd., Bio-Rad Laboratories, Inc., Waters Corporation, Caprion Biosciences (acquired by GHO Capital), and Qiagen N.V. are the major companies operating in the market.

Table of Contents
Product Code: 24608

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REAGENTS ARE THE WIDELY USED PROTEOMICS COMPONENT
    • 3.2.2. DISEASE DIAGNOSIS IS THE FASTEST GROWING APPLICATION
    • 3.2.3. DRUG DISCOVERY AND DEVELOPMENT IS THE MAJORLY USED END-USER

4. MARKET DETERMINANTS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. ADVANCEMENT IN PROTEOMIC TECHNOLOGIES
    • 4.2.2. INCREASE IN R&D EXPENDITURE
    • 4.2.3. TECHNOLOGICAL ADVANCEMENTS
    • 4.2.4. INCREASING USE OF PROTEOMICS INFORMATION
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF INSTRUMENTS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. IDENTIFICATION OF NOVEL BIOMARKERS
    • 4.4.2. WIDESPREAD USE OF MASS SPECTROMETER TO STUDY PROTEIN-PROTEIN INTERACTION
  • 4.5. MARKET CHALLENGES
    • 4.5.1. LACK OF SKILLED PROFESSIONALS
    • 4.5.2. STRINGENT REGULATIONS

5. MARKET BY APPLICATION

  • 5.1. DRUG DISCOVERY
  • 5.2. DISEASE DIAGNOSIS
  • 5.3. OTHER APPLICATION

6. MARKET BY COMPONENT

  • 6.1. REAGENTS
  • 6.2. INSTRUMENTS
  • 6.3. SERVICES

7. KEY ANALYTICS

  • 7.1. PORTER'S FIVE FORCES MODEL
    • 7.1.1. THREAT OF NEW ENTRANTS
    • 7.1.2. THREAT OF SUBSTITUTE
    • 7.1.3. BARGAINING POWER OF BUYERS
    • 7.1.4. BARGAINING POWER OF SUPPLIERS
    • 7.1.5. THREAT OF COMPETITIVE RIVALRY
  • 7.2. PROTEOMICS INDUSTRY ANALYSIS
  • 7.3. APPLICATIONS OF PROTEOMIC IN DRUG DISCOVERY AND DEVELOPMENT
  • 7.4. SCIENTIFIC INITIATIVES IN PROTEOMICS
  • 7.5. PATENT ANALYSIS
  • 7.6. OPPORTUNITY MATRIX

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. GERMANY
    • 8.1.2. FRANCE
    • 8.1.3. THE UNITED KINGDOM
    • 8.1.4. ITALY
    • 8.1.5. SPAIN
    • 8.1.6. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

  • 9.1. MARKET POSITION ANALYSIS
  • 9.2. COMPANY PROFILES
    • 9.2.1. AGILENT TECHNOLOGIES, INC.
    • 9.2.2. BIO-RAD LABORATORIES, INC.
    • 9.2.3. BRUKER CORPORATION
    • 9.2.4. CAPRION BIOSCIENCES (ACQUIRED BY GHO CAPITAL)
    • 9.2.5. DANAHER CORPORATION
    • 9.2.6. GENERAL ELECTRIC COMPANY
    • 9.2.7. GLAXOSMITHKLINE
    • 9.2.8. HORIBA, LTD.
    • 9.2.9. LI-COR INC
    • 9.2.10. LUMINEX CORP.
    • 9.2.11. MERCK & COMPANY INC.
    • 9.2.12. PERKINELMER, INC.
    • 9.2.13. QIAGEN N.V.
    • 9.2.14. THERMO FISHER SCIENTIFIC INC.
    • 9.2.15. WATERS CORPORATION

TABLES LIST

  • TABLE 1 EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • TABLE 2 EUROPE PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 3 EUROPE DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)
  • TABLE 4 EUROPE DISEASE DIAGNOSIS MARKET 2019-2027 ($ MILLION)
  • TABLE 5 EUROPE OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
  • TABLE 6 EUROPE PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 7 EUROPE REAGENTS MARKET 2019-2027 ($ MILLION)
  • TABLE 8 EUROPE INSTRUMENTS MARKET 2019-2027 ($ MILLION)
  • TABLE 9 GENERAL WORKFLOW OF MASS SPECTROMETRY (MS)
  • TABLE 10 EUROPE SERVICES MARKET 2019-2027 ($ MILLION)
  • TABLE 11 STATUS OF THE MAJOR PROTEOMICS INDUSTRIES
  • TABLE 12 ARRAY-RELATED PROTEOMICS PATENTS 2015-2018 (%)
  • TABLE 13 LOC-RELATED PROTEOMICS PATENTS 2015-2018 (%)
  • TABLE 14 MASS SPECTROMETRY-RELATED PROTEOMICS PATENTS 2015-2018(%)
  • TABLE 15 EUROPE PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 16 GERMANY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 17 GERMANY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 18 FRANCE PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 19 FRANCE PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 20 THE UNITED KINGDOM PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 21 THE UNITED KINGDOM PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 22 ITALY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 23 ITALY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 24 SPAIN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 25 SPAIN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 26 PROTEOMICS COMPANY MARKET POSITION ANALYSIS 2017

FIGURES LIST

  • FIGURE 1 EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 EUROPE PROTEOMICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 3 EUROPE PROTEOMICS MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)
  • FIGURE 4 EUROPE PROTEOMICS MARKET BY DISEASE DIAGNOSIS 2019-2027 ($ MILLION)
  • FIGURE 5 EUROPE PROTEOMICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
  • FIGURE 6 EUROPE PROTEOMICS MARKET SHARE BY COMPONENT 2018 & 2027 (%)
  • FIGURE 7 EUROPE PROTEOMICS MARKET BY REAGENTS 2019-2027 ($ MILLION)
  • FIGURE 8 EUROPE PROTEOMICS MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)
  • FIGURE 9 EUROPE PROTEOMICS MARKET BY SERVICES 2019-2027 ($ MILLION)
  • FIGURE 10 PORTER'S FIVE FORCE MODEL
  • FIGURE 11 GERMANY PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 12 FRANCE PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 13 THE UNITED KINGDOM PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 14 ITALY PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 15 SPAIN PROTEOMICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 16 REST OF EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)
Back to Top